Cardiologist's Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

American Journal of Cardiology

Volumn 99, Issue 4 SUPPL., 2007, Pages 3-5

  Gotto Jr , Antonio M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CULTURAL FACTOR; DIABETIC PATIENT; DRUG EFFECT; DYSLIPIDEMIA; EDITORIAL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; THROMBOGENESIS;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; PHYSICIAN'S ROLE; RISK FACTORS;

EID: 33846939358     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.001     Document Type: Editorial

References (27)

1. American Diabetes Association. National diabetes fact sheet, 2005. Available at: http://www.diabetes.org/uedocuments/NationalDiabetesFactSheetRev.pdf. Accessed March 31, 2006.
2. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 suppl (2006) S4-S32
3. Haffner S., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
4. Grundy S., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., Mitch W., Smith Jr. S.C., and Sowers J.R. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
6. Schering D., and Kasten S. The link between diabetes and cardiovascular disease. J Pharm Pract 17 (2004) 61-65
7. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 433-444
8. Ford E. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 28 (2005) 1769-1778
9. Wong N.D. Screening and risk stratification of patients with the metabolic syndrome and diabetes. Expert Rev Cardiovasc Ther 4 (2006) 181-190
10. Grundy S. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47 (2006) 1093-1110
11. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
12. Leiter L.A., and Fitchet D. Optimal care of cardiovascular disease and type 2 diabetes patients: shared responsibilities between the cardiologist and diabetologist. Atheroscler Suppl 7 (2006) 37-42
13. Betteridge D.J. Treating dyslipidaemia in the patient with type 2 diabetes. Eur Heart J 6 suppl (2004) C28-C33
14. Kannel W.B., and Larson M. Long-term epidemiologic prediction of coronary disease: the Framingham experience. Cardiology 82 (1993) 137-152
15. Ferrucci L., Furberg C.D., Penninx B.W., DiBari M., Williamson J.D., Guralnik J.M., Chen J.G., Applegate W.B., and Pahor M. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 104 (2001) 1923-1926
16. Haffner S. Diabetes and the metabolic syndrome-when is it best to intervene to protect?. Atheroscler Suppl 7 (2006) 3-10
17. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
18. Pechere-Bertschi A., Greminger P., Hess L., Philippe J., and Ferrari P. Swiss Hypertension and Risk Factor Program (SHARP): cardiovascular risk factors management in patients with type 2 diabetes in Switzerland. Blood Press 14 (2005) 337-344
19. Stern M.P. The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes. Arch Fam Med 7 (1998) 155-162
20. Calkin A.C., and Allen T.J. Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention. Am J Cardiovasc Drugs 6 (2006) 15-40
21. Lebovitz H. Diabetes: assessing the pipeline. Atheroscler Suppl 7 (2006) 43-49
22. Duncan G.E. Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome. Curr Diab Rep 6 (2006) 29-35
23. Ridderstrale M., Gudbjornsdottir S., Eliasson B., Nilsson P.M., Cederholm J., and Steering Committee of the Swedish National Diabetes Register (NDR). Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med 3 (2006) 314-322
24. Johnstone M.T., and Veves A. Diabetes and Cardiovascular Disease. 2nd ed. (2005), Humana Press, Totowa, NJ
25. Marso S.P., and Stern D.M. Diabetes and Cardiovascular Disease: Integrating Science and Clinical Medicine (2004), Lippincott Williams & Wilkins, Philadelphia
26. Gotto A.M., and Pownall H.J. Manual of Lipid Disorders: Reducing the Risk for Coronary Heart Disease. 3rd ed. (2003), Lippincott Williams & Wilkins, Philadelphia 430-440
27. Liburd L.C., Jack L., Williams S., and Tucker P. Intervening on the social determinants of cardiovascular disease and diabetes. Am J Prev Med 29 (2005) 18-24